Cargando…

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma

BACKGROUND: Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-field relapses. We investigated the dosimetric eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoppe, Bradford S., Mailhot Vega, Raymond B., Mendenhall, Nancy P., Sandler, Eric S., Slayton, William B., Katzenstein, Howard, Joyce, Michael J., Li, Zuofeng, Flampouri, Stella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302731/ https://www.ncbi.nlm.nih.gov/pubmed/32582815 http://dx.doi.org/10.14338/IJPT-19-00077.1

Ejemplares similares

Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
por: Figura, Nick, et al.
Publicado: (2017)

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
por: Guzhva, Lidia, et al.
Publicado: (2019)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer
por: Liang, Xiaoying, et al.
Publicado: (2020)

Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques
por: Su, Zhong, et al.
Publicado: (2019)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
por: Saifi, Omran, et al.
Publicado: (2023)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Damage to the Superior Retinae After 30 Gy Whole-Brain Radiation
por: Chan, Lawrence, et al.
Publicado: (2021)

Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
por: Mailhot Vega, Raymond B., et al.
Publicado: (2021)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension
por: Egan, Pamela C., et al.
Publicado: (2019)

0.5-Gy X-ray irradiation induces reorganization of cytoskeleton and differentiation of osteoblasts
por: Huang, Qun, et al.
Publicado: (2021)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
por: Kharod, Shivam M., et al.
Publicado: (2020)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Mediastinal irradiation and valvular heart disease
por: Patil, Shivaraj, et al.
Publicado: (2022)

Initial damage produced by a single 15-Gy x-ray irradiation to the rat calvaria skin
por: da Silva Santin, Matheus, et al.
Publicado: (2020)

Emergency irradiation of 3.4Gy/2f in pineal gland germinoma patients with symptomatic hydrocephalus
por: Li, Bo, et al.
Publicado: (2019)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
por: Milgrom, Sarah A., et al.
Publicado: (2019)

Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas
por: Saleh, Khalil, et al.
Publicado: (2020)

Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)
por: Widder, J, et al.
Publicado: (2005)

ESR investigation of sucrose radicals produced by 0.25−4.5 Gy doses of X-ray irradiation
por: Nakagawa, Kouichi, et al.
Publicado: (2014)

Simvastatin mitigates increases in risk factors for and the occurrence of cardiac disease following 10 Gy total body irradiation
por: Lenarczyk, Marek, et al.
Publicado: (2015)

Repeated 0.2-Gy γ-Ray Irradiation Attenuates the Inflammatory Process and Endotoxin Damage Induced by Lipopolysaccharides
por: Dong, Suhe, et al.
Publicado: (2019)

Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies
por: Hirabayashi, Koichi, et al.
Publicado: (2014)

Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
por: Latorre, Javier Anchuelo, et al.
Publicado: (2018)

Comparison of transcriptional profiles in human lymphocyte cells irradiated with (12)C ion beams at 0–2.0 Gy
por: Zhang, Ruifeng, et al.
Publicado: (2019)

Emergency irradiation with 3.4 Gy/2f in sellar/suprasellar germinoma patients with rapid visual acuity decline
por: Li, Bo, et al.
Publicado: (2019)

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
por: Pepper, Niklas Benedikt, et al.
Publicado: (2020)

Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma
por: Nilak, Yash Dilip, et al.
Publicado: (2019)

Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma
por: Dubois, Sydney, et al.
Publicado: (2021)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l1pdacfpdgpsb16pehu5fsavrm